We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of FPRX yet.

FPRX Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q2 2021, worth a combined $0 — down 100% from $1.56B a quarter earlier.

Sellers outnumbered buyers: 147 funds closed out of FPRX and 0 opened new positions — a net loss of 147 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $239M sold.

  • 0 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q2 2021, down from 147 in Q1 2021.
  • Funds reported $0 of Five Prime Therapeutics, Inc. stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Five Prime Therapeutics, Inc. positions in Q2 2021 and 147 closed out, a net change of -147 holders.
  • The largest Five Prime Therapeutics, Inc. seller in Q2 2021 was BVF Inc, an estimated $239M sold.

Based on aggregated 13F filings for Q2 2021.